Popp N, Powell R, Wheelock M, Holmes K, Zapp B, Sheldon K
bioRxiv. 2025; .
PMID: 39975210
PMC: 11838247.
DOI: 10.1101/2024.04.01.587474.
Zacchi L, Roche-Recinos D, Pegg C, Phung T, Napoli M, Aitken C
Commun Biol. 2021; 4(1):390.
PMID: 33758337
PMC: 7988164.
DOI: 10.1038/s42003-021-01903-x.
Gao W, Xu Y, Liu H, Gao M, Cao Q, Wang Y
Blood Adv. 2020; 4(15):3659-3667.
PMID: 32766856
PMC: 7422117.
DOI: 10.1182/bloodadvances.2020002520.
Chang X, Hou Y
Int J Biochem Mol Biol. 2018; 9(1):1-10.
PMID: 29531845
PMC: 5840312.
Xu Q, Hou Y, Chang X
Mol Ther Nucleic Acids. 2017; 7:429-438.
PMID: 28624219
PMC: 5443964.
DOI: 10.1016/j.omtn.2017.05.005.
Biological Insights into Therapeutic Protein Modifications throughout Trafficking and Their Biopharmaceutical Applications.
Zhong X, Wright J
Int J Cell Biol. 2013; 2013:273086.
PMID: 23690780
PMC: 3652174.
DOI: 10.1155/2013/273086.
Modification of the N-terminus of human factor IX by defective propeptide cleavage or acetylation results in a destabilized calcium-induced conformation: effects on phospholipid binding and activation by factor XIa.
Wojcik E, van den Berg M, Poort S, Bertina R
Biochem J. 1997; 323 ( Pt 3):629-36.
PMID: 9169594
PMC: 1218364.
DOI: 10.1042/bj3230629.
Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp).
Brennan S, Hammonds B, George P
J Clin Invest. 1995; 96(6):2854-8.
PMID: 8675656
PMC: 185996.
DOI: 10.1172/JCI118356.
Haemophilia B (sixth edition): a database of point mutations and short additions and deletions.
Giannelli F, Green P, Sommer S, Poon M, Ludwig M, Schwaab R
Nucleic Acids Res. 1996; 24(1):103-18.
PMID: 8594556
PMC: 145614.
DOI: 10.1093/nar/24.1.103.
Intracellular maturation of the gamma-carboxyglutamic acid (Gla) region in prothrombin coincides with release of the propeptide.
Wallin R, Stanton C, Hutson S
Biochem J. 1993; 291 ( Pt 3):723-7.
PMID: 8489500
PMC: 1132428.
DOI: 10.1042/bj2910723.
Haemophilia B: database of point mutations and short additions and deletions--fourth edition, 1993.
Giannelli F, Green P, High K, Sommer S, Poon M, Ludwig M
Nucleic Acids Res. 1993; 21(13):3075-87.
PMID: 8392713
PMC: 309734.
DOI: 10.1093/nar/21.13.3075.
Haemophilia B: database of point mutations and short additions and deletions, fifth edition, 1994.
Giannelli F, Green P, Sommer S, Lillicrap D, Ludwig M, Schwaab R
Nucleic Acids Res. 1994; 22(17):3534-46.
PMID: 7937052
PMC: 308314.
DOI: 10.1093/nar/22.17.3534.
Evolution of prothrombin: isolation and characterization of the cDNAs encoding chicken and hagfish prothrombin.
Banfield D, Irwin D, Walz D, MacGillivray R
J Mol Evol. 1994; 38(2):177-87.
PMID: 7513365
DOI: 10.1007/BF00166164.
The propeptide region of clotting factor IX is a signal for a vitamin K dependent carboxylase: evidence from protein engineering of amino acid -4.
Galeffi P, Brownlee G
Nucleic Acids Res. 1987; 15(22):9505-13.
PMID: 3684602
PMC: 306484.
DOI: 10.1093/nar/15.22.9505.
Precursors to regulatory peptides: their proteolytic processing.
Andrews P, Brayton K, Dixon J
Experientia. 1987; 43(7):784-90.
PMID: 3297766
DOI: 10.1007/BF01945356.
A factor IX mutation, verified by direct genomic sequencing, causes haemophilia B by a novel mechanism.
Tsang T, Bentley D, MIBASHAN R, Giannelli F
EMBO J. 1988; 7(10):3009-15.
PMID: 3181127
PMC: 454685.
DOI: 10.1002/j.1460-2075.1988.tb03164.x.
Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.
Schach B, Yoshitake S, Davie E
J Clin Invest. 1987; 80(4):1023-8.
PMID: 2821070
PMC: 442341.
DOI: 10.1172/JCI113155.
Vitamin K-dependent carboxylase: affinity purification from bovine liver by using a synthetic propeptide containing the gamma-carboxylation recognition site.
HUBBARD B, Ulrich M, Jacobs M, Vermeer C, Walsh C, Furie B
Proc Natl Acad Sci U S A. 1989; 86(18):6893-7.
PMID: 2780546
PMC: 297956.
DOI: 10.1073/pnas.86.18.6893.
Molecular pathology of haemophilia B.
Green P, Bentley D, MIBASHAN R, Nilsson I, Giannelli F
EMBO J. 1989; 8(4):1067-72.
PMID: 2743975
PMC: 400915.
DOI: 10.1002/j.1460-2075.1989.tb03474.x.
Three point mutations in the factor IX genes of five hemophilia B patients. Identification strategy using localization by altered epitopes in their hemophilic proteins.
Chen S, Thompson A, Zhang M, Scott C
J Clin Invest. 1989; 84(1):113-8.
PMID: 2472424
PMC: 303960.
DOI: 10.1172/JCI114130.